tiprankstipranks
Trending News
More News >
Astellas Pharma’s ASP3082 Study: A Potential Game-Changer in Oncology
PremiumCompany AnnouncementsAstellas Pharma’s ASP3082 Study: A Potential Game-Changer in Oncology
5d ago
Astellas Pharma’s Fezolinetant Study: A Potential Game-Changer for Menopausal Treatment
Premium
Company Announcements
Astellas Pharma’s Fezolinetant Study: A Potential Game-Changer for Menopausal Treatment
5d ago
Astellas Pharma’s New Study on ASP3021: A Potential Game-Changer for AMD Treatment
Premium
Company Announcements
Astellas Pharma’s New Study on ASP3021: A Potential Game-Changer for AMD Treatment
12d ago
Astellas Pharma Reports Higher Than Expected Financial Results
PremiumCompany AnnouncementsAstellas Pharma Reports Higher Than Expected Financial Results
2M ago
ALPMF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ALPMF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
FDA Approves Extended Use of Astellas’ IZERVAY for Geographic Atrophy
Premium
Company Announcements
FDA Approves Extended Use of Astellas’ IZERVAY for Geographic Atrophy
5M ago
Astellas Pharma’s Resubmission for IZERVAY Accepted by FDA
PremiumCompany AnnouncementsAstellas Pharma’s Resubmission for IZERVAY Accepted by FDA
6M ago
Astellas Faces FDA Setback on IZERVAY Application
Premium
Company Announcements
Astellas Faces FDA Setback on IZERVAY Application
8M ago
Astellas Pharma Faces Currency Losses in FY2024
Premium
Company Announcements
Astellas Pharma Faces Currency Losses in FY2024
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100